아시아태평양의 의료용 외골격 시장 예측(-2031년) : 지역별 분석(컴포넌트별, 유형별, 사지별, 용도별, 이동성별, 최종 사용자별)

Asia Pacific Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component, Type, Extremity, Application, Mobility, and End Users

US $ 3,450 ￦ 4,981,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450 ￦ 6,424,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,450 ￦ 7,868,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

아시아태평양의 의료용 외골격 시장은 2023년 7,643만 달러로 평가되었고, 2031년에는 7억 2,020만 달러에 이를 것으로 예측되며, 2023년부터 2031년까지 CAGR 32.4%로 추정됩니다.

SCI의 유병률 증가가 아시아태평양의 의료용 외골격 시장을 밀어 올립니다.

신체 활동의 저하와 좌식 활동이 우세해지면 SCI를 앓고있는 사람들의 신체적, 심리적 심각한 악화로 이어질 수 있습니다. 국립의학 도서관에 따르면, 세계에서는 매년 25만-50만명의 환자가 SCI에 시달리고 있습니다. Lifeward와 같은 기업은 SCI 환자가 통증없이 신체 활동을 할 수있게 해주는 외골격 개발에 주력합니다. 예를 들어, SCI 인구의 약 20%는 현재 ReWalk Personal Exoskeleton 또는 ReWalk Rehabilitation Exoskeleton의 임상시험 후보자로 생각할 수 있습니다. 또한 의료용 외골격의 소프트 외골격 슈트 장치는 SCI를 앓고 있는 환자에게 사용할 수 있습니다.

아시아태평양의 의료용 외골격 시장 개요

아시아태평양의 의료용 외골격 시장은 말레이시아, 태국, 인도, 싱가포르, 필리핀, 베트남, 인도네시아, 중국, 일본, 호주, 한국, 기타 아시아태평양으로 세분화됩니다.

아시아태평양의 의료용 외골격 시장의 수익과 2031년까지의 예측(금액 기준)

아시아태평양의 의료용 외골격 시장 세분화

아시아태평양의 의료용 외골격 시장은 구성 요소, 유형, 사지, 용도, 이동성, 최종 사용자, 국가로 분류됩니다.

컴포넌트별로, 아시아태평양의 의료용 외골격 시장은 하드웨어와 소프트웨어로 분류됩니다.

유형별로는 아시아태평양의 의료용 외골격 시장은 동력식 외골격과 수동식 외골격으로 본류됩니다.

사지별로 아시아태평양의 의료용 외골격 시장은 하반신용 외골격, 상반신용 외골격, 전신용 외골격으로 구분됩니다.

용도별로 아시아태평양의 의료용 외골격 시장은 척수 손상, 다발성 경화증, 뇌졸중, 뇌성 마비, 파킨슨병 등으로 구분됩니다.

모빌리티별로, 아시아태평양의 의료용 외골격 시장은 이동식 외골격과 거치형 외골격으로 분류됩니다.

최종 사용자별로 아시아태평양의 의료용 외골격 시장은 재활센터, 물리치료 센터, 장기 간호 센터, 재택 간호 등으로 구분됩니다. 2023년 아시아태평양의 의료용 외골격 시장에서는 재활센터 분야가 최대 점유율을 차지했습니다.

국가별로 아시아태평양의 의료용 외골격 시장은 중국, 일본, 인도, 한국, 호주 및 기타 아시아태평양으로 구분됩니다. 2023년 아시아태평양의 의료용 외골격 시장에서는 일본 시장이 가장 큰 점유율을 차지했습니다.

BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; and Rex Bionics Ltd.는 아시아태평양의 의료용 외골격 시장에서 활동하는 주요 기업입니다.

목차

제1장 서론

제2장 주요 요약

• 주요 인사이트
• 시장의 매력

제3장 분석 방법

• 2차 조사
• 1차 조사
  • 가설의 책정
  • 거시경제 요인분석
  • 기초 수치의 개발
  • 데이터의 삼각측량
  • 국가 레벨 데이터

제4장 의료용 외골격 시장 : 주요 시장 역학

• 의료용 외골격 시장 : 주요 시장 역학
• 시장 성장 촉진요인
  • 전략적 이니셔티브 증가
  • 뇌졸중 및 근골격계의 이환율 증가
  • 고령자의 장수화
• 시장 성장 억제요인
  • 제품 비용 상승과 규제 우려
• 시장 기회
  • SCI의 유병률 증가
• 향후의 동향
  • 기술 진보와 투자 증가
• 성장 촉진요인과 억제요인의 영향

제5장 의료용 외골격 시장 : 아시아태평양 분석

• 의료용 외골격 시장의 수익(2021-2031년)
• 의료용 외골격 시장 예측 분석

제6장 의료용 외골격 시장 분석 : 컴포넌트별

• 하드웨어
• 소프트웨어

제7장 의료용 외골격 시장의 분석 : 유형별

• 동력식 외골격
• 수동식 외골격

제8장 의료용 외골격 시장 분석 : 사지별

• 하반신용 외골격
• 상반신용 외골격
• 전신용 외골격

제9장 의료용 외골격 시장의 분석 : 용도별

• 척수 손상
• 다발성 경화증
• 뇌졸중
• 뇌성 마비
• 파킨슨병
• 기타

제10장 의료용 외골격 시장의 분석 : 모빌리티별

• 이동식 외골격
• 거치형 외골격

제11장 의료용 외골격 시장 분석 : 최종 사용자별

• 재활센터
• 물리치료 센터
• 장기 간호 센터
• 재택 간호
• 기타

제12장 아시아태평양의 의료용 외골격 시장 : 국가별 분석

• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주
  • 아시아태평양의 기타 국가

제13장 의료용 외골격 시장 : 업계 정세

• 개요
• 의료용 외골격 시장에서의 성장 전략
• 유기적 성장 전략
• 무기적 성장 전략

제14장 기업 프로파일

• Ekso Bionics Holdings Inc
• Lifeward, Inc
• ExoAtlet
• Cyberdyne Inc
• BIONIK
• B-Temia Inc
• Hocoma AG
• Myomo Inc
• Rex Bionics Ltd.

제15장 부록

JHS

영문 목차

영문목차

The Asia Pacific medical exoskeleton market was valued at US$ 76.43 million in 2023 and is expected to reach US$ 720.20 million by 2031; it is estimated to register a CAGR of 32.4% from 2023 to 2031.

Increasing Prevalence of SCI Boosts Asia Pacific Medical Exoskeleton Market

Reduced physical activity and the predominance of seated activities can lead to severe physical and psychological deterioration in people suffering from SCI. Secondary complications related to SCI can also reduce life expectancies. According to the National Library of Medicine, nearly 250,000-500,000 patients suffer from SCIs every year worldwide. An elevated number of cases is attributed to motocross and motorcycling competitions emerging as the most popular sporting activities worldwide, as per the National Institute of Health report. According to the WHO, globally, ~1.19 million people die every year in road crashes, and 20-50 million people suffer non-fatal injuries, with many incurring disabilities. Companies such as Lifeward are focusing on developing exoskeletons that help patients with SCI perform physical activities without pain. For instance, about 20% of the SCI population can be considered candidates for clinical trials of the current ReWalk Personal Exoskeleton or ReWalk Rehabilitation Exoskeleton. Moreover, soft exo-suit devices in medical exoskeletons can be used for patients suffering from SCI. Thus, the increase in the prevalence of SCI and ongoing research for the use of exoskeletons for SCI patients can be expected to fuel the market growth during the forecast period.

Asia Pacific Medical Exoskeleton Market Overview

The medical exoskeleton market in Asia Pacific is sub segmented into Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing chronic diseases, growing technological advancements, and surging number of startups are the factors favoring the market progress in this region.

Asia Pacific Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Medical Exoskeleton Market Segmentation

The Asia Pacific medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.

By component, the Asia Pacific medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.

In terms of type, the Asia Pacific medical exoskeleton market is bifurcated into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.

Based on extremity, the Asia Pacific medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.

By application, the Asia Pacific medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.

In terms of mobility, the Asia Pacific medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.

By end users, the Asia Pacific medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.

Based on country, the Asia Pacific medical exoskeleton market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Japan segment held the largest share of Asia Pacific medical exoskeleton market in 2023.

BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; and Rex Bionics Ltd. are some of the leading companies operating in the Asia Pacific medical exoskeleton market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Medical Exoskeleton Market - Key Market Dynamics

• 4.1 Medical Exoskeleton Market - Key Market Dynamics
• 4.2 Market Drivers:
  • 4.2.1 Rising Number of Strategic Initiatives
  • 4.2.2 Growing Incidence of Stroke and Musculoskeletal
  • 4.2.3 Increasing Longevity of Aging Population
• 4.3 Market Restraints
  • 4.3.1 High Cost of Product and Regulatory Concerns
• 4.4 Market Opportunities
  • 4.4.1 Increasing Prevalence of SCI
• 4.5 Future Trends
  • 4.5.1 Increasing Technological Advancements and Rising Investments
• 4.6 Impact of Drivers and Restraints:

5. Medical Exoskeleton Market - Asia Pacific Analysis

• 5.1 Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
• 5.2 Medical Exoskeleton Market Forecast Analysis

6. Medical Exoskeleton Market Analysis - by Component

• 6.1 Hardware
  • 6.1.1 Overview
  • 6.1.2 Hardware: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 6.2 Software
  • 6.2.1 Overview
  • 6.2.2 Software: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

7. Medical Exoskeleton Market Analysis - by Type

• 7.1 Powered Exoskeleton
  • 7.1.1 Overview
  • 7.1.2 Powered Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 7.2 Passive Exoskeleton
  • 7.2.1 Overview
  • 7.2.2 Passive Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

8. Medical Exoskeleton Market Analysis - by Extremity

• 8.1 Lower Body Exoskeleton
  • 8.1.1 Overview
  • 8.1.2 Lower Body Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 8.2 Upper Body Exoskeleton
  • 8.2.1 Overview
  • 8.2.2 Upper Body Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 8.3 Full Body Exoskeleton
  • 8.3.1 Overview
  • 8.3.2 Full Body Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

9. Medical Exoskeleton Market Analysis - by Application

• 9.1 Spinal Cord Injury
  • 9.1.1 Overview
  • 9.1.2 Spinal Cord Injury: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 9.2 Multiple Sclerosis
  • 9.2.1 Overview
  • 9.2.2 Multiple Sclerosis: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 9.3 Stroke
  • 9.3.1 Overview
  • 9.3.2 Stroke: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 9.4 Cerebral Palsy
  • 9.4.1 Overview
  • 9.4.2 Cerebral Palsy: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 9.5 Parkinson's Diseases
  • 9.5.1 Overview
  • 9.5.2 Parkinson's Diseases: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

10. Medical Exoskeleton Market Analysis - by Mobility

• 10.1 Mobile Exoskeleton
  • 10.1.1 Overview
  • 10.1.2 Mobile Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 10.2 Stationary Exoskeleton
  • 10.2.1 Overview
  • 10.2.2 Stationary Exoskeleton: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

11. Medical Exoskeleton Market Analysis - by End Users

• 11.1 Rehabilitation Centers
  • 11.1.1 Overview
  • 11.1.2 Rehabilitation Centers: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 11.2 Physiotherapy Centers
  • 11.2.1 Overview
  • 11.2.2 Physiotherapy Centers: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 11.3 Long Term Care Centers
  • 11.3.1 Overview
  • 11.3.2 Long Term Care Centers: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 11.4 Homecare Settings
  • 11.4.1 Overview
  • 11.4.2 Homecare Settings: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
• 11.5 Others
  • 11.5.1 Overview
  • 11.5.2 Others: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Medical Exoskeleton Market - Country Analysis

• 12.1 Asia Pacific
  • 12.1.1 Asia Pacific Medical Exoskeleton Market Overview
  • 12.1.2 Asia Pacific Medical Exoskeleton Market - Revenue and Forecast Analysis - by Country
    • 12.1.2.1 China: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
      • 12.1.2.1.1 China: Medical Exoskeleton Market Breakdown, by Component
      • 12.1.2.1.1.1 China: Medical Exoskeleton Market Breakdown, by Hardware
      • 12.1.2.1.1.1.1 China: Medical Exoskeleton Market Breakdown, by Actuators
      • 12.1.2.1.2 China: Medical Exoskeleton Market Breakdown, by Type
      • 12.1.2.1.3 China: Medical Exoskeleton Market Breakdown, by Extremity
      • 12.1.2.1.4 China: Medical Exoskeleton Market Breakdown, by Application
      • 12.1.2.1.5 China: Medical Exoskeleton Market Breakdown, by Mobility
      • 12.1.2.1.6 China: Medical Exoskeleton Market Breakdown, by End Users
    • 12.1.2.2 Japan: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
      • 12.1.2.2.1 Japan: Medical Exoskeleton Market Breakdown, by Component
      • 12.1.2.2.1.1 Japan: Medical Exoskeleton Market Breakdown, by Hardware
      • 12.1.2.2.1.1.1 Japan: Medical Exoskeleton Market Breakdown, by Actuators
      • 12.1.2.2.2 Japan: Medical Exoskeleton Market Breakdown, by Type
      • 12.1.2.2.3 Japan: Medical Exoskeleton Market Breakdown, by Extremity
      • 12.1.2.2.4 Japan: Medical Exoskeleton Market Breakdown, by Application
      • 12.1.2.2.5 Japan: Medical Exoskeleton Market Breakdown, by Mobility
      • 12.1.2.2.6 Japan: Medical Exoskeleton Market Breakdown, by End Users
    • 12.1.2.3 India: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
      • 12.1.2.3.1 India: Medical Exoskeleton Market Breakdown, by Component
      • 12.1.2.3.1.1 India: Medical Exoskeleton Market Breakdown, by Hardware
      • 12.1.2.3.1.1.1 India: Medical Exoskeleton Market Breakdown, by Actuators
      • 12.1.2.3.2 India: Medical Exoskeleton Market Breakdown, by Type
      • 12.1.2.3.3 India: Medical Exoskeleton Market Breakdown, by Extremity
      • 12.1.2.3.4 India: Medical Exoskeleton Market Breakdown, by Application
      • 12.1.2.3.5 India: Medical Exoskeleton Market Breakdown, by Mobility
      • 12.1.2.3.6 India: Medical Exoskeleton Market Breakdown, by End Users
    • 12.1.2.4 South Korea: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
      • 12.1.2.4.1 South Korea: Medical Exoskeleton Market Breakdown, by Component
      • 12.1.2.4.1.1 South Korea: Medical Exoskeleton Market Breakdown, by Hardware
      • 12.1.2.4.1.1.1 South Korea: Medical Exoskeleton Market Breakdown, by Actuators
      • 12.1.2.4.2 South Korea: Medical Exoskeleton Market Breakdown, by Type
      • 12.1.2.4.3 South Korea: Medical Exoskeleton Market Breakdown, by Extremity
      • 12.1.2.4.4 South Korea: Medical Exoskeleton Market Breakdown, by Application
      • 12.1.2.4.5 South Korea: Medical Exoskeleton Market Breakdown, by Mobility
      • 12.1.2.4.6 South Korea: Medical Exoskeleton Market Breakdown, by End Users
    • 12.1.2.5 Australia: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
      • 12.1.2.5.1 Australia: Medical Exoskeleton Market Breakdown, by Component
      • 12.1.2.5.1.1 Australia: Medical Exoskeleton Market Breakdown, by Hardware
      • 12.1.2.5.1.1.1 Australia: Medical Exoskeleton Market Breakdown, by Actuators
      • 12.1.2.5.2 Australia: Medical Exoskeleton Market Breakdown, by Type
      • 12.1.2.5.3 Australia: Medical Exoskeleton Market Breakdown, by Extremity
      • 12.1.2.5.4 Australia: Medical Exoskeleton Market Breakdown, by Application
      • 12.1.2.5.5 Australia: Medical Exoskeleton Market Breakdown, by Mobility
      • 12.1.2.5.6 Australia: Medical Exoskeleton Market Breakdown, by End Users
    • 12.1.2.6 Rest of APAC: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
      • 12.1.2.6.1 Rest of APAC: Medical Exoskeleton Market Breakdown, by Component
      • 12.1.2.6.1.1 Rest of APAC: Medical Exoskeleton Market Breakdown, by Hardware
      • 12.1.2.6.1.1.1 Rest of APAC: Medical Exoskeleton Market Breakdown, by Actuators
      • 12.1.2.6.2 Rest of APAC: Medical Exoskeleton Market Breakdown, by Type
      • 12.1.2.6.3 Rest of APAC: Medical Exoskeleton Market Breakdown, by Extremity
      • 12.1.2.6.4 Rest of APAC: Medical Exoskeleton Market Breakdown, by Application
      • 12.1.2.6.5 Rest of APAC: Medical Exoskeleton Market Breakdown, by Mobility
      • 12.1.2.6.6 Rest of APAC: Medical Exoskeleton Market Breakdown, by End Users

13. Medical Exoskeleton Market - Industry Landscape

• 13.1 Overview
• 13.2 Growth Strategies in Medical Exoskeleton Market
• 13.3 Organic Growth Strategies
  • 13.3.1 Overview
• 13.4 Inorganic Growth Strategies
  • 13.4.1 Overview

14. Company Profiles

• 14.1 Ekso Bionics Holdings Inc
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
• 14.2 Lifeward, Inc
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
• 14.3 ExoAtlet
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
• 14.4 Cyberdyne Inc
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
• 14.5 BIONIK
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
• 14.6 B-Temia Inc
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
• 14.7 Hocoma AG
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
• 14.8 Myomo Inc
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
• 14.9 Rex Bionics Ltd.
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments

15. Appendix

• 15.1 About Us
• 15.2 Glossary of Terms

관련자료